Trial intelligence / Profile preview

DIC075V vs Ketorolac in Post-Operative Pain

NCT00507026Phase 3Completed

Sponsor
Pfizer
Start
Jul 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diclofenac in postoperative pain (3 arms), sponsored by Pfizer. Primary endpoints: Sum of the Pain Intensity Differences Over 24 Hours, Sum of the Pain Intensity Differences Over 48 Hours and 3 more. Started Jul 2007; status: completed.

02

Drugs

diclofenac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00507026.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00507026.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call